0001359620-21-000005.txt : 20211222 0001359620-21-000005.hdr.sgml : 20211222 20211222151616 ACCESSION NUMBER: 0001359620-21-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 EFFECTIVENESS DATE: 20211222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vero Biotech Inc. CENTRAL INDEX KEY: 0001359620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204604159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-426342 FILM NUMBER: 211512943 BUSINESS ADDRESS: STREET 1: 387 TECHNOLOGY CIR. NW STREET 2: SUITE 125 CITY: ATLANTA STATE: GA ZIP: 30313 BUSINESS PHONE: 678-862-7729 MAIL ADDRESS: STREET 1: 387 TECHNOLOGY CIR. NW STREET 2: SUITE 125 CITY: ATLANTA STATE: GA ZIP: 30313 FORMER COMPANY: FORMER CONFORMED NAME: Geno LLC DATE OF NAME CHANGE: 20060417 D 1 primary_doc.xml X0708 D LIVE 0001359620 Vero Biotech Inc. 387 TECHNOLOGY CIR. NW SUITE 125 ATLANTA GA GEORGIA 30313 678-862-7729 DELAWARE Geno LLC Corporation true Todd Brady c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Director Daniel Salazar c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Director Brent V. Furse c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Executive Officer Director Thiago Tavares c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Director Eric Bednarski c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Director Roberto Cohen c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Executive Officer Shasha Zou c/o Vero Biotech Inc. 55 Ivan Allen Jr. Blvd. NW, Ste. 525 Atlanta GA GEORGIA 30308 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-12-08 false true false 0 99530958 27265773 72265185 false 5 0 0 0 false Vero Biotech Inc. /s/ Brent V. Furse Brent V. Furse President & CEO 2021-12-22